Literature DB >> 31432442

Survey of Infection Control Precautions for Patients with Severe Combined Immune Deficiency.

Brieanne A Dergousoff1, Joseph V Vayalumkal1,2,3, Nicola A M Wright4.   

Abstract

Severe combined immune deficiency (SCID) is caused by an array of genetic disorders resulting in a diminished adaptive immune system due to impaired T lymphocytes. In these patients, active infection at the time of hematopoietic transplantation has been shown to increase morbidity and mortality. To prevent transmission of infections in SCID patients, standardized infection control precautions should be implemented. An online survey regarding SCID-specific protocols was distributed through several immunodeficiency organizations. Seventy-three responses were obtained, with the majority (55%) of responses from the USA, 15% from Canada, and the remainder from 12 other countries. Only 50% of respondents had a SCID-specific infection control protocol at their center, and while a majority of these centers had training for physicians, a small minority had training for other healthcare workers such as nursing and housekeeping staff. Significant variability of infection control practices, such as in-patient precautions, required personal protective equipment (PPE), diet restrictions, visitor precautions and discharge criteria, was found between different treatment centers. There is a paucity of evidence-based data regarding the safest environment to prevent infection in SCID patients. Institutional protocols may have significant impact on infection risk, survival, family well-being, child development and cost of care. From these results, it is evident that further multi-center research is required to determine the safest and healthiest environment for these children, so that evidence-based infection control protocols for patients with SCID can be developed.

Entities:  

Keywords:  Severe combined immune deficiency; healthcare-associated infections; infection control; transmission

Mesh:

Year:  2019        PMID: 31432442     DOI: 10.1007/s10875-019-00671-y

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  3 in total

Review 1.  Congenital Athymia: Genetic Etiologies, Clinical Manifestations, Diagnosis, and Treatment.

Authors:  Cathleen Collins; Emily Sharpe; Abigail Silber; Sarah Kulke; Elena W Y Hsieh
Journal:  J Clin Immunol       Date:  2021-05-13       Impact factor: 8.317

Review 2.  Hematopoietic Stem Cell Transplantation for Severe Combined Immunodeficiency (SCID).

Authors:  Elie Haddad; Manfred Hoenig
Journal:  Front Pediatr       Date:  2019-11-19       Impact factor: 3.418

3.  Infections in Infants with SCID: Isolation, Infection Screening, and Prophylaxis in PIDTC Centers.

Authors:  Morna J Dorsey; Nicola A M Wright; Natalia S Chaimowitz; Blachy J Dávila Saldaña; Holly Miller; Michael D Keller; Monica S Thakar; Ami J Shah; Rolla Abu-Arja; Jeffrey Andolina; Victor Aquino; J L Barnum; Jeffrey J Bednarski; Monica Bhatia; Francisco A Bonilla; Manish J Butte; Nancy J Bunin; Sharat Chandra; Sonali Chaudhury; Karin Chen; Hey Chong; Geoffrey D E Cuvelier; Jignesh Dalal; Magee L DeFelice; Kenneth B DeSantes; Lisa R Forbes; Alfred Gillio; Fred Goldman; Avni Y Joshi; Neena Kapoor; Alan P Knutsen; Lisa Kobrynski; Jay A Lieberman; Jennifer W Leiding; Benjamin Oshrine; Kiran P Patel; Susan Prockop; Troy C Quigg; Ralph Quinones; Kirk R Schultz; Christine Seroogy; David Shyr; Subhadra Siegel; Angela R Smith; Troy R Torgerson; Mark T Vander Lugt; Lolie C Yu; Morton J Cowan; Rebecca H Buckley; Christopher C Dvorak; Linda M Griffith; Elie Haddad; Donald B Kohn; Brent Logan; Luigi D Notarangelo; Sung-Yun Pai; Jennifer Puck; Michael A Pulsipher; Jennifer Heimall
Journal:  J Clin Immunol       Date:  2020-10-02       Impact factor: 8.317

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.